Loading: 100%
VARIAN MEDICAL SYSTEMS INC logo
no logo available
General Information
Investor relations pageIR page no data available
Founding year no data available
Headquarter Palo Alto, United States of AmericaPalo Alto, United States of Americano data available
Employees 7,800 (as per Q3 2017)no data available
Sector Medical Devices, HealthcareMedical Devices, Healthcareno data available
Ticker VARno data available
Financial year endsFY ends End of Septemberno data available
Stock Information (historical prices adjusted for splits and dividends)
Adj. Closing prices (in USD) -Common sharesNov. 16Jan. 17März 17Mai 17Juli 17Sep. 17708090100110
datesClosing price (adj.)
13.10.2017102.70
11.10.2017100.91
04.10.2017101.96
27.09.2017101.60
20.09.2017106.98
13.09.2017107.68
06.09.2017106.73
30.08.2017103.86
23.08.2017100.91
16.08.201799.71
09.08.201796.20
02.08.201798.21
26.07.2017102.59
19.07.2017105.42
12.07.2017104.84
05.07.2017103.72
27.06.2017102.65
20.06.2017104.07
13.06.2017102.01
06.06.2017101.91
30.05.201798.78
23.05.201795.95
16.05.201795.95
09.05.201796.01
02.05.201791.19
25.04.201788.37
18.04.201788.41
11.04.201790.04
04.04.201791.24
28.03.201791.35
21.03.201790.74
14.03.201788.23
07.03.201786.06
28.02.201783.89
21.02.201783.54
14.02.201780.60
07.02.201778.43
31.01.201777.65
24.01.201790.30
17.01.201790.06
10.01.201789.99
03.01.201790.68
27.12.201691.58
19.12.201691.11
12.12.201691.48
05.12.201690.10
28.11.201691.08
21.11.201689.66
14.11.201687.84
07.11.201691.07
31.10.201690.73
24.10.201697.57
17.10.201695.87
no share price data source found
Share price data requested
Key Figures
Last Closing Price
as per Oct 13, 2017, in USD
102.70n/a
Market Capitalisation
in million USD
9,428n/a
Enterprise Value
in million USD
9,138n/a
Common Shares Outstanding
as per Jul 28, 2017
91,800,894n/a
Preferred Shares Outstanding
as per Jul 28, 2017
n/a
Average Basic Shares Outstanding
TTM
92,983,250n/a
Average Diluted Shares Outstanding
TTM
93,761,500n/a
Index Membership
n/a
Business Summary
Varian Medical Systems Inc is engaged in the healthcare sector. It manufactures medical devices for conditions with radiotherapy, radiosurgery, proton therapy and brachytherapy.
no data available
Key Financials & Ratios (all figures TTM as per Jun 30, 2017, million USD, full statements further below)
Profit & Loss
Revenues 3,132n/a
Gross Profit 1,354n/a
Operating Income 514n/a
EBITDA 596n/a
Net Profit 284n/a
Balance Sheet
Cash and Cash Equivalents 658n/a
Receivables 748n/a
Total Current Assets 2,059n/a
PP&E 249n/a
Total Assets 3,059n/a
Accounts Payable 153n/a
Current Debt 114n/a
Total Current Liabilities 1,273n/a
Long-Term Debt 250n/a
Total Liabilities 1,665n/a
Total Equity 1,394n/a
Cash Flow
Depreciation & Amortisation 82n/a
Change in Working Capital -32n/a
Operating Cash Flow 421n/a
Net Change in PP&E and Intangibles -60n/a
Investing Cash Flow -128n/a
Dividends Paid 0n/a
Financing Cash Flow -473n/a
Total Change in Cash -176n/a
Free Cash Flow 368n/a
Profitability Ratios
Gross Margin 43.2%n/a
Operating Margin 16.4%n/a
Net Profit Margin 9.1%n/a
Return on Equity 20.5%n/a
Return on Assets 9.3%n/a
Per Share Figures
Basic EPS 3.06n/a
Diluted EPS 3.03n/a
Sales per Share 33.68n/a
Book Value per Share 14.95n/a
FCF per Share 3.96n/a
Dividends per Share 0.00n/a
Price Multiples
Price to Earnings Ratio 33.58n/a
Price to Sales Ratio 3.05n/a
Price to Book Value 6.85n/a
Price to Free Cash Flow 25.94n/a
Valuation Metrics
EV/EBITDA 15.33n/a
EV/Sales 2.92n/a
Book to Market Value 0.15n/a
Other Ratios
Current Ratio 161.7%n/a
Liabilities to Equity Ratio 119.4%n/a
Debt to Assets Ratio 11.9%n/a
Profit & Loss StatementP&L data quality: 100% (?)
edit
No data available yet
Loading data...
No data available for the original financial statements for the selected time periods. You can change the selected time periods by clicking on 'data' on the top right.
Standardised statements can't be displayed.
Reason:
No data available for the selected time periods
in million USD FY '07FY '08FY '09FY '10FY '11FY '12FY '13FY '14FY '15FY '16
Revenue
1,755
2,070
2,214
2,357
2,597
2,807
2,943
3,050
3,099
3,218
Sales & Services Revenue
0
0
0
0
0
0
0
0
0
0
Financing Revenue
0
0
0
0
0
0
0
0
0
0
Other Revenue
0
0
0
0
0
0
0
0
0
0
Cost of revenue
-1,022
-1,192
-1,254
-1,331
-1,461
-1,611
-1,693
-1,748
-1,816
-1,857
Cost of Goods & Services
0
0
0
0
0
0
0
0
0
0
Cost of Financing Revenue
0
0
0
0
0
0
0
0
0
0
Cost of Other Revenue
0
0
0
0
0
0
0
0
0
0
Gross Profit
733
878
961
1,026
1,136
1,196
1,250
1,302
1,283
1,361
Other Operating Income
0
0
0
0
0
0
0
0
0
0
Operating Expenses
-394
-458
-486
-491
-547
-602
-641
-705
-734
-794
Selling, General & Administrative
-277
-323
-339
-335
-377
-417
-433
-471
-489
-540
Selling & Marketing
0
0
0
0
0
0
0
0
0
0
General & Administrative
0
0
0
0
0
0
0
0
0
0
Research & Development
-117
-136
-147
-157
-171
-186
-208
-235
-245
-254
Depreciation & Amortization
0
0
0
0
0
0
0
0
0
0
Provision For Doubtful Accounts
0
0
0
0
0
0
0
0
0
0
Other Operating Expense
0
0
0
0
0
0
0
0
0
0
Operating Income (Loss)
339
419
474
534
588
594
609
596
549
568
Non-Operating Income (Loss)
7
7
0
-1
0
2
3
3
6
6
Interest Expense, net
7
7
0
-1
0
2
3
3
6
6
Interest Expense
0
0
0
0
0
0
0
0
0
0
Interest Income
0
0
0
0
0
0
0
0
0
0
Other Investment Income (Loss)
0
0
0
0
0
0
0
0
0
0
Foreign Exchange Gain (Loss)
0
0
0
0
0
0
0
0
0
0
Income (Loss) from Affiliates
0
0
0
0
0
0
0
0
0
0
Other Non-Operating Income (Loss)
0
0
0
0
0
0
0
0
0
0
Pretax Income (Loss), Adjusted
346
426
475
533
589
596
612
600
555
573
Abnormal Gains (Losses)
0
0
0
0
0
0
0
-25
0
-17
Acquired In-Process R&D
0
0
0
0
0
0
0
0
0
0
Merger / Acquisition Expense
0
0
0
0
0
0
0
0
0
0
Abnormal Derivatives
0
0
0
0
0
0
0
0
0
0
Disposal of Assets
0
0
0
0
0
0
0
0
0
0
Early extinguishment of Debt
0
0
0
0
0
0
0
0
0
0
Asset Write-Down
0
0
0
0
0
0
0
0
0
0
Impairment of Goodwill & Intangibles
0
0
0
0
0
0
0
0
0
0
Sale of Business
0
0
0
0
0
0
0
0
0
0
Legal Settlement
0
0
0
0
0
0
0
0
0
0
Restructuring Charges
0
0
0
0
0
0
0
0
0
0
Sale of and Unrealized Investments
0
0
0
0
0
0
0
0
0
0
Insurance Settlement
0
0
0
0
0
0
0
0
0
0
Other Abnormal Items
0
0
0
0
0
0
0
0
0
0
Pretax Income (Loss)
346
426
475
533
589
596
612
575
555
556
Income Tax (Expense) Benefit, net
-103
-131
-143
-165
-180
-169
-174
-171
-143
-154
Current Income Tax
0
0
0
0
0
0
0
0
0
0
Deferred Income Tax
0
0
0
0
0
0
0
0
0
0
Tax Allowance/Credit
0
0
0
0
0
0
0
0
0
0
Income (Loss) from Affiliates, net of taxes
0
0
0
0
0
0
0
0
0
0
Income (Loss) from Continuing Operations
243
295
331
367
409
427
438
404
412
403
Net Extraordinary Gains (Losses)
-3
-16
-12
-7
-10
0
0
0
0
0
Discontinued Operations
-3
-16
-12
-7
-10
0
0
0
0
0
XO & Accounting Charges & Other
0
0
0
0
0
0
0
0
0
0
Income (Loss) Including Minority Interest
239
279
319
360
399
427
438
404
412
403
Minority Interest
0
0
0
0
0
0
0
0
-1
0
Net Income
239
279
319
360
399
427
438
404
412
402
Preferred Dividends
0
0
0
0
0
0
0
0
0
0
Other Adjustments
0
0
0
0
0
0
0
0
0
0
Net Income Available to Common Shareholders
239
279
319
360
399
427
438
404
412
402
Remarks
restated on Nov 25, 2009 n/a
calculated values,
restated on May 5, 2011 n/a
calculated values,
restated on Nov 23, 2011 n/a
calculated values,
restated on Nov 21, 2012 n/a
calculated values,
restated on Nov 26, 2013 n/a
calculated values,
restated on Nov 25, 2014 n/a
calculated values,
restated on Nov 25, 2015 n/a
calculated values,
restated on Nov 23, 2016 n/a
calculated values,
restated on Nov 23, 2016 n/a
calculated values,
restated on Nov 23, 2016 n/a
calculated values,
Balance SheetBS data quality: 100% (?)
edit
No data available yet
Loading data...
No data available for the original financial statements for the selected time periods. You can change the selected time periods by clicking on 'data' on the top right.
Standardised statements can't be displayed.
Reason:
No data available for the selected time periods
in million USD FY '07FY '08FY '09FY '10FY '11FY '12FY '13FY '14FY '15FY '16
Assets
Cash, Cash Equivalents & Short Term Investments
n/a
397
554
520
584
754
1,181
915
846
907
Cash & Cash Equivalents
n/a
397
554
520
564
705
1,118
849
846
811
Short Term Investments
n/a
0
0
0
19
50
63
66
0
95
Accounts & Notes Receivable
n/a
486
581
592
635
692
698
732
771
770
Accounts Receivable, Net
n/a
486
581
592
635
692
698
732
771
770
Notes Receivable, Net
n/a
0
0
0
0
0
0
0
0
0
Unbilled Revenues
n/a
0
0
0
0
0
0
0
0
0
Inventories
n/a
283
322
364
410
458
535
572
613
442
Raw Materials
n/a
0
0
0
0
0
0
0
0
0
Work In Process
n/a
0
0
0
0
0
0
0
0
0
Finished Goods
n/a
0
0
0
0
0
0
0
0
0
Other Inventory
n/a
0
0
0
0
0
0
0
0
0
Other Short Term Assets
n/a
97
72
87
112
151
168
149
164
497
Prepaid Expenses
n/a
78
72
87
112
151
168
149
164
141
Derivative & Hedging Assets
n/a
0
0
0
0
0
0
0
0
0
Assets Held-for-Sale
n/a
0
0
0
0
0
0
0
0
0
Deferred Tax Assets
n/a
0
0
0
0
0
0
0
0
0
Income Taxes Receivable
n/a
0
0
0
0
0
0
0
0
0
Discontinued Operations
n/a
19
0
0
0
0
0
0
0
356
Miscellaneous Short Term Assets
n/a
0
0
0
0
0
0
0
0
0
Total Current Assets
n/a
1,263
1,528
1,563
1,741
2,055
2,583
2,368
2,393
2,615
Property, Plant & Equipment, Net
n/a
218
264
268
286
297
315
338
379
259
Property, Plant & Equipment
n/a
0
0
0
0
0
0
0
0
0
Accumulated Depreciation
n/a
0
0
0
0
0
0
0
0
0
Long Term Investments & Receivables
n/a
0
0
0
0
0
0
0
0
0
Long Term Investments
n/a
0
0
0
0
0
0
0
0
0
Long Term Marketable Securities
n/a
0
0
0
0
0
0
0
0
0
Long Term Receivables
n/a
0
0
0
0
0
0
0
0
0
Other Long Term Assets
n/a
494
516
493
472
527
571
651
807
941
Intangible Assets
n/a
0
0
0
0
0
0
0
73
84
Goodwill
n/a
209
210
208
212
222
225
241
284
220
Other Intangible Assets
n/a
0
0
0
0
0
0
0
0
0
Prepaid Expense
n/a
0
0
0
0
0
0
0
0
0
Deferred Tax Assets
n/a
131
144
118
114
116
122
126
119
137
Derivative & Hedging Assets
n/a
0
0
0
0
0
0
0
0
0
Prepaid Pension Costs
n/a
0
0
0
0
0
0
0
0
0
Discontinued Operations
n/a
3
0
0
0
0
0
0
0
273
Investments in Affiliates
n/a
0
0
0
0
0
0
0
0
0
Miscellaneous Long Term Assets
n/a
151
161
166
146
189
223
285
331
227
Total Noncurrent Assets
n/a
712
780
761
758
824
886
989
1,186
1,199
Total Assets
n/a
1,976
2,308
2,324
2,499
2,879
3,468
3,357
3,579
3,815
Liabilities and owners' equity
Payables & Accruals
n/a
358 358196000
420 420495000
407 406869000
445 444955000
517 517304000
515 515156000
559 559085000
550 550100000
543 542800000
Accounts Payable
n/a
105 105281000
116 116093000
119 119018000
155 154946000
181 180736000
194 194272000
187 187377000
203 202900000
159 159200000
Accrued Taxes
n/a
0 0
0 0
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Interest & Dividends Payable
n/a
0 0
0 0
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Other Payables & Accruals
n/a
253 252915000
304 304402000
288 287851000
290 290009000
337 336568000
321 320884000
372 371708000
347 347200000
384 383600000
Short Term Debt
n/a
8 7987000
13 13450000
26 25525000
191 191276000
155 155000000
56 56250000
50 50000000
158 158400000
379 379000000
Short Term Borrowings
n/a
0 0
0 0
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Short Term Capital Leases
n/a
0 0
0 0
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Current Portion of Long Term Debt
n/a
0 0
0 0
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Other Short Term Liabilities
n/a
415 415494000
408 408375000
471 471147000
490 489681000
564 564227000
589 589173000
593 592569000
668 668200000
692 691600000
Deferred Revenue
n/a
141 141368000
131 130588000
142 141916000
140 140173000
369 369456000
389 389479000
422 421845000
668 668200000
609 608600000
Derivatives & Hedging
n/a
0 0
0 0
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Deferred Tax Liabilities
n/a
0 0
0 0
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Discontinued Operations
n/a
21 21202000
0 0
0 0
0 0
0 0
0 0
0 0
0 0
83 83000000
Miscellaneous Short Term Liabilities
n/a
253 252924000
278 277787000
329 329231000
350 349508000
195 194771000
200 199694000
171 170724000
0 0
0 0
Total Current Liabilities
n/a
782 781677000
842 842320000
904 903541000
1,126 1125912000
1,237 1236531000
1,161 1160579000
1,202 1201654000
1,377 1376700000
1,613 1613400000
Long Term Debt
n/a
32 32399000
23 23394000
18 17869000
6 6250000
6 6250000
450 450000000
388 387500000
338 337500000
287 286900000
Long Term Borrowings
n/a
0 0
0 0
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Long Term Capital Leases
n/a
0 0
0 0
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Other Long Term Liabilities
n/a
134 134251000
131 130751000
127 127175000
123 122708000
126 126169000
144 144048000
152 151716000
138 138200000
160 160000000
Accrued Liabilities
n/a
0 0
0 0
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Pension Liabilities
n/a
0 0
0 0
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Pensions
n/a
0 0
0 0
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Other Post-Retirement Benefits
n/a
0 0
0 0
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Deferred Compensation
n/a
0 0
0 0
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Deferred Revenue
n/a
0 0
0 0
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Deferred Tax Liabilities
n/a
0 0
0 0
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Derivatives & Hedging
n/a
0 0
0 0
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Discontinued Operations
n/a
0 0
0 0
0 0
0 0
0 0
0 0
0 0
0 0
4 4200000
Miscellaneous Long Term Liabilities
n/a
134 134251000
131 130751000
127 127175000
123 122708000
126 126169000
144 144048000
152 151716000
138 138200000
156 155800000
Total Noncurrent Liabilities
n/a
167 166650000
154 154145000
145 145044000
129 128958000
132 132419000
594 594048000
539 539216000
476 475700000
447 446900000
Total Liabilities
n/a
948 948327000
996 996465000
1,049 1048585000
1,255 1254870000
1,369 1368950000
1,755 1754627000
1,741 1740870000
1,852 1852400000
2,060 2060300000
Preferred Equity
n/a
0 0
0 0
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Share Capital & Additional Paid-In Capital
n/a
594 593974000
642 641759000
626 626373000
613 613266000
673 673282000
744 743575000
744 743790000
780 780300000
772 772300000
Common Stock
n/a
0 0
0 0
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Additional Paid in Capital
n/a
0 0
0 0
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Other Share Capital
n/a
0 0
0 0
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Treasury Stock
n/a
0 0
0 0
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Retained Earnings
n/a
451 451439000
696 696409000
687 686598000
677 677473000
893 893115000
1,010 1010343000
931 931241000
1,018 1017800000
1,069 1069000000
Other Equity
n/a
-18 -18228000
-26 -26385000
-38 -37604000
-47 -46848000
-57 -56621000
-40 -40071000
-59 -58611000
-87 -86500000
-101 -100800000
Equity Before Minority Interest
n/a
1,027 1027185000
1,312 1311783000
1,275 1275367000
1,244 1243891000
1,510 1509776000
1,714 1713847000
1,616 1616420000
1,712 1711600000
1,741 1740500000
Minority Interest
n/a
0 0
0 0
0 0
0 0
0 0
0 0
0 0
15 14700000
14 14000000
Total Equity
n/a
1,027 1027185000
1,312 1311783000
1,275 1275367000
1,244 1243891000
1,510 1509776000
1,714 1713847000
1,616 1616420000
1,726 1726300000
1,755 1754500000
Total Liabilities & Equity
n/a
1,976 1975512000
2,308 2308248000
2,324 2323952000
2,499 2498761000
2,879 2878726000
3,468 3468474000
3,357 3357290000
3,579 3578700000
3,815 3814800000
Remarks restated on n/a restated on Nov 25, 2009 n/a restated on May 5, 2011 n/a restated on Nov 23, 2011 n/a restated on Nov 21, 2012 n/a restated on Nov 26, 2013 n/a restated on Nov 25, 2014 n/a restated on Nov 25, 2015 n/a restated on Nov 23, 2016 n/a restated on Aug 8, 2017 n/a
Cash Flow StatementCF data quality: 97% (?)
edit
No data available yet
Loading data...
No data available for the original financial statements for the selected time periods. You can change the selected time periods by clicking on 'data' on the top right.
Standardised statements can't be displayed.
Reason:
No data available for the selected time periods
in million USD FY '07FY '08FY '09FY '10FY '11FY '12FY '13FY '14FY '15FY '16
Net Income/Starting Line
239
279
319
360
399
427
438
404
412
403
Net Income
0
0
0
0
0
0
0
0
0
0
Net Income From Discontinued Operations
0
0
0
0
0
0
0
0
0
0
Other Adjustments
0
0
0
0
0
0
0
0
0
0
Depreciation & Amortization
32
37
45
48
53
61
63
63
69
80
Non-Cash Items
46
51
13
76
77
56
40
71
54
31
Stock-Based Compensation
0
0
0
0
0
0
0
0
0
0
Deferred Income Taxes
0
0
0
0
0
0
0
0
0
0
Other Non-Cash Adjustments
0
0
0
0
0
0
0
0
0
0
Change in Working Capital
-17
5
-88
-24
-56
-51
-86
-88
-65
-158
(Increase) Decrease in Accounts Receivable
0
0
0
0
0
0
0
0
0
0
(Increase) Decrease in Inventories
0
0
0
0
0
0
0
0
0
0
Increase (Decrease) in Accounts Payable
0
0
0
0
0
0
0
0
0
0
Increase (Decrease) in Other
0
0
0
0
0
0
0
0
0
0
Net Cash From Discontinued Operations (operating)
0
0
0
0
0
0
0
0
0
0
Cash from Operating Activities
300
372
288
461
473
493
455
449
470
356
Change in Fixed Assets & Intangibles
-64
-81
-63
-68
-71
-61
-76
-90
-91
-80
Disposition of Fixed Assets & Intangibles
0
0
0
0
0
0
0
0
0
0
Disposition of Fixed Assets
0
0
0
0
0
0
0
0
0
0
Disposition of Intangible Assets
0
0
0
0
0
0
0
0
0
0
Acquisition of Fixed Assets & Intangibles
0
0
0
0
0
0
0
0
0
0
Purchase of Fixed Assets
0
0
0
0
0
0
0
0
0
0
Acquisition of Intangible Assets
0
0
0
0
0
0
0
0
0
0
Other Change in Fixed Assets & Intangibles
0
0
0
0
0
0
0
0
0
0
Net Change in Long Term Investment
69
-8
0
0
-33
-31
-10
-7
-1
5
Decrease in Long Term Investment
0
0
0
0
0
0
0
0
0
0
Increase in Long Term Investment
0
0
0
0
0
0
0
0
0
0
Net Cash From Acquisitions & Divestitures
0
0
0
0
0
0
0
0
0
0
Net Cash from Divestitures
0
0
0
0
0
0
0
0
0
0
Cash for Acqusition of Subsidiaries
0
0
0
0
0
0
0
0
0
0
Cash for Joint Ventures
0
0
0
0
0
0
0
0
0
0
Net Cash from Other Acquisitions
0
0
0
0
0
0
0
0
0
0
Other Investing Activities
-61
2
-15
-7
-14
-31
-10
-36
-118
-34
Net Cash From Discontinued Operations (investing)
0
0
0
0
0
0
0
0
0
0
Cash from Investing Activities
-56
-88
-78
-75
-118
-122
-96
-133
-211
-109
Dividends Paid
0
0
0
0
0
0
0
0
0
0
Cash From (Repayment of) Debt
26
-50
-4
-16
49
-36
345
-69
59
167
Cash From (Repayment of) Short Term Debt, net
0
0
0
0
0
0
0
0
0
0
Cash From (Repayment of) Long Term Debt, net
0
0
0
0
0
0
0
0
0
0
Repayments of Long Term Debt
0
0
0
0
0
0
0
0
0
0
Cash From Long Term Debt
0
0
0
0
0
0
0
0
0
0
Cash From (Repurchase of) Equity
-319
-262
-101
-498
-505
-257
-420
-628
-422
-461
Increase in Capital Stock
0
0
0
0
0
0
0
0
0
0
Decrease in Capital Stock
-319
-262
-101
-498
-505
-257
-420
-628
-422
-461
Other Financing Activities
52
169
34
91
145
59
127
101
87
48
Net Cash From Discontinued Operations (financing)
0
0
0
0
0
0
0
0
0
0
Cash from Financing Activities
-241
-142
-71
-422
-311
-235
52
-596
-277
-246
Net Cash Before Disc. Operations and FX
4
143
139
-36
44
136
411
-280
-18
1
Change in Cash from Disc. Operations and Other
0
0
0
0
0
0
0
0
0
0
Net Cash Before FX
4
143
139
-36
44
136
411
-280
-18
1
Effect of Foreign Exchange Rates
-13
-9
1
3
1
4
3
11
14
-3
Net Changes in Cash
-9
134
140
-33
44
140
413
-269
-4
-2
Remarks
restated on Nov 25, 2009 n/a
calculated values,
restated on May 5, 2011 n/a
calculated values,
restated on Nov 23, 2011 n/a
calculated values,
restated on Nov 21, 2012 n/a
calculated values,
restated on Nov 26, 2013 n/a
calculated values,
restated on Nov 25, 2014 n/a
calculated values,
restated on Nov 25, 2015 n/a
calculated values,
restated on Nov 23, 2016 n/a
calculated values,
restated on Nov 23, 2016 n/a
calculated values,
restated on Nov 23, 2016 n/a
calculated values,
Some of the data shown on this page is provided for free by IEX
Sumo